Results 301 to 310 of about 453,877 (390)

<i>De Novo</i> donor-specific anti-HLA antibody risk stratification in kidney transplantation using a combination of B cell and T cell molecular mismatch assessment. [PDF]

Front Immunol
Chou-Wu E, Niemann M, Youngs D, Gimferrer I.   +3 more
europepmc   +1 more source

Focal adhesion kinase mediates human leukocyte histocompatibility antigen class II‐induced signaling in gingival fibroblasts

, 2007
Sayuri Yoshizawa, Michio Meguro, Hideki Ohyama, Kazu Takeuchi‐Hatanaka, Sho Matsushita, Shogo Takashiba, Fusanori Nishimura   +6 more
openalex   +2 more sources

Clinico‐sero‐pathological characteristics of anti‐Ha antisynthetase syndrome

Brain Pathology, Volume 35, Issue 3, May 2025.
A necrotizing myopathy without a perifascicular pattern is the most common pathological manifestation of anti‐Ha ASS. Abstract To define the clinical, serological, and muscle histopathological characteristics, as well as treatment outcomes, of patients with anti‐Ha antibody.
Bing Zhao, Ying Hou, Kai Shao, XiaoTian Ma, YaPing Yan, Jian‐Qiang Lu, Wei Li, ChuanZhu Yan, LiNing Zhang, TingJun Dai   +9 more
wiley   +1 more source

The 2024 IPD-MHC database update: a comprehensive resource for major histocompatibility complex studies. [PDF]

Nucleic Acids Res
Maccari G, Robinson J, Barker DJ, Yates AD, Hammond JA, Marsh SGE.   +5 more
europepmc   +1 more source

Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis

Brain Pathology, EarlyView.
Graphical representation of the widespread white matter (blue color mask) and grey matter (cortical and deep grey matter; red color mask) demyelination in MS cases characterized by substantial inflammation of the CP (A). The presence of lesions was mainly associated with periventricular white matter and hippocampus areas (A).
R. Magliozzi, S. Hametner, M. Mastantuono, A. Mensi, M. Karimian, L. Griffiths, L. M. Watkins, A. Poli, G. M. Berti, E. Barusolo, B. Bellini, S. Rossi, D. Gveric, J. A. Stratton, K. Akassoglou, S. Magon, R. Nicholas, R. Reynolds, O. W. Howell, S. Monaco   +19 more
wiley   +1 more source

Chronic Hepatitis B Virus Infection and HLA Variations in a Greek Population. [PDF]

Viruses
Myserli E, Goulis I, Fylaktou A, Exindari M, Minti F, Chatzika G, Iliopoulou E, Agorastou P, Papagiouvanni I, Oikonomou T, Gioula G.   +10 more
europepmc   +1 more source

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

British Journal of Pharmacology, EarlyView.
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley   +1 more source

Influence of CDC‑XM and HLA compatibility on clinical outcomes in kidney transplant recipients during the post‑operative recovery period: A retrospective analysis. [PDF]

Exp Ther Med
Xie S, Xu C, Zhu Z, Qin C, Song X, Wang X, Xu W, Zhu M.   +7 more
europepmc   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer. [PDF]

BMC Cancer
Ando Y, Miyadera H, Bando H, Hashimoto S, Noguchi E, Hara H.   +5 more
europepmc   +1 more source